infusion

(redirected from continuous subcutaneous insulin infusion)
Also found in: Dictionary, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to continuous subcutaneous insulin infusion: insulin pump
  • noun

Synonyms for infusion

Synonyms for infusion

a solution obtained by steeping or soaking a substance (usually in water)

the process of extracting certain active properties (as a drug from a plant) by steeping or soaking (usually in water)

Related Words

(medicine) the passive introduction of a substance (a fluid or drug or electrolyte) into a vein or between tissues (as by gravitational force)

the act of infusing or introducing a certain modifying element or quality

Related Words

References in periodicals archive ?
Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service.
Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
Continuous subcutaneous insulin infusion (CSII) is a well known and successful method used in type 1 diabetic patients (7,8).
Assessment of Therapy with Continuous Subcutaneous Insulin Infusion in an Academic Diabetes Clinic.
It is developing an Ambulatory Diabetes Pump to be used for continuous subcutaneous insulin infusion.
Founded in 2000, the company seeks to improve the lives of people with diabetes - and to break down the barriers to Continuous Subcutaneous Insulin Infusion (CSII) therapy - through innovative design and technology, and through feedback from people with diabetes, physicians and diabetes educators.
Founded in 2000, the company seeks to improve the lives of people with diabetes, and to break down the barriers to continuous subcutaneous insulin infusion (CSII) therapy, through technology and through communication with healthcare professionals and those personally afflicted.
Based on insights from diabetes patients, educators and physicians, Insulet created a new solution that integrates the proven healthcare benefits of continuous subcutaneous insulin infusion (CSII) therapy with blood glucose monitoring technology in a safe, convenient and discreet two-part system.
NASDAQ: HALO) today announced the presentation of two posters at the 72nd Scientific Sessions of the American Diabetes Association (ADA) highlighting its research on improved treatment options for both the multiple daily injection therapy and continuous subcutaneous insulin infusion markets.
Full browser ?